首页 产品中心 抗体 生化试剂 研究领域
服务与支持 定制服务 技术支持 促销活动 关于我们
登 录 注 册

LATS1/2 Antibody  (货号:AYP4809)

A
小A 扫码咨询
宿主: Rabbit克隆性: Polyclonal反应: Human,MouseWBIHCELISA
说明书    复制信息    复制引用

货号:AYP4809

规格价格
50 μL ¥1150.00 加购物车
100 μL ¥2100.00 加购物车
反应 Human,Mouse
宿主 Rabbit
克隆性 Polyclonal
应用 WBIHCELISA
推荐浓度 WB: 1:500 - 1:2000
IHC: 1:50 - 1:200
理论分子量 76kDa/126kDa
实测分子量
形式 Liquid
保存条件 Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.75% BSA,50% glycerol,pH7.3.
偶联物 Unconjugated
阳性对照 HeLa
细胞定位 Cytoplasm,centrosome,cytoskeleton,microtubule organizing center
纯化 Affinity purification

相关产品

查找相关产品 >>

抗原信息

抗原信息 Synthesized peptide derived from Human LATS1/2.
序列
查看序列
AHSLV

靶点信息

研究背景 The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.
基因 ID 9113, 26524
基因名 LATS1,LATS2
Swiss O95835Q9NRM7
别名 LATS1;WARTS;wts

实验步骤

实验步骤
AYP4809